NanoViricides

Read more
Anil R. Diwan's photo - President of NanoViricides

President

Anil R. Diwan

CEO Approval Rating

90/100

Founded:

2005

Status:

PublicIndependent CompanyNYSENNVC

NANOVIRICIDES TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Anil R. Diwan

President

- -
17
$32.2M
$4.6M
View Profile
1

Severin Schwan

CEO

89/100
100,000
$600K
$66.1B
View Profile
2

Dame Emma Walmsley

CEO

74/100
94,066
- -
$45.2B
View Profile
3

Jon P. Stonehouse

President & CEO

79/100
100
$328.5M
$32M
View Profile
4

Michael A. Sherman

President & CEO

83/100
82
$274.6M
$5.6M
View Profile
5

Christopher U. Missling

President & CEO

89/100
16
$60.6M
$10.9M
View Profile
6

Stephane Bancel

CEO

73/100
760
$3.6B
$2.7B
View Profile
7

Brian Pereira

President & CEO

89/100
70
$141.2M
$3M
View Profile
8

Jon Pilcher

CEO

90/100
10
$8.4M
$ < 1M
View Profile
9

R. Brian McKernan

Co-Founder & CEO

72/100
97
$53.8M
$25M
View Profile
10

Nava Zisapel

Co-Founder & CEO

90/100
57
- -
$12M
View Profile

Missing a competitor? Contribute!

NanoViricides Quarterly and Annual Revenue

Coming soon for NanoViricides!

Annual Revenue

$4.6M

NanoViricides's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 10.4B.

NanoViricides Acquisitions

No recent acquisitions found related to NanoViricides

NanoViricides Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Jul 2020
$11.5M
-
Private Placement
May 2020
$10.2M
-
Debt
Dec 2019
$2M
-
Equity
Feb 2019
$2.5M
-
Debt
Jan 2013
$6M
-

NanoViricides Investments

No recent investments found related to NanoViricides

NanoViricides News

NanoViricides Press Releases

Social Media

NanoViricides Headquarters

1 Controls Drive

Shelton, Connecticut06484

203-937-6137

Driving Directions »

Trending Companies

NanoViricides Summary

ABOUT

Overview

NanoViricides is a pharmaceutical company that develops and commercializes nanomedicines for the treatment of viral diseases. NanoViricides was founded in 2005. NanoViricides' headquarters is located in Shelton, Connecticut, USA 06484. It has raised 3...

CEO

NanoViricides's President, Anil R. Diwan, currently has an approval rating of 90%. NanoViricides's primary competitors are Roche, GSK & BioCryst.

Frequently Asked Questions about NanoViricides

  1. When was NanoViricides founded?

    NanoViricides was founded in 2005
  2. Who is NanoViricides's CEO?

    NanoViricides's CEO is Anil R. Diwan
  3. How much revenue does NanoViricides generate?

    NanoViricides generates $4.6M in revenue
  4. How much funding does NanoViricides have?

    NanoViricides has historically raised $32.2M in funding
  1. Where is NanoViricides's headquarters?

    NanoViricides's headquarters is in Shelton Connecticut, USA
  2. How many employees does NanoViricides have?

    NanoViricides has 17 employees
  3. What sector does NanoViricides operate in?

    NanoViricides is in Pharmaceuticals
  4. Who are NanoViricides's competitors?

    NanoViricides's top competitors are Roche, GSK, BioCryst